MODE is a product development phase company preparing a pipeline of user friendly and clinically informative diagnostic products for the Over-The-Counter (OTC) retail pharmacy market. MODE’s focus is Health & Awareness in Cancer & Infectious Disease and provides retail customers access to early detection and disease management products.
MODE’s proprietary electrochemical detection technology enables high precision diagnostics using robust proven sensors that can be integrated into easy to use handheld test devices that are designed for low cost, high volume manufacturing.
MODE’s first product, called measure, is a consumer-friendly, easy to use test that assesses bowel health and aids the early detection of bowel cancer. It is available to purchase on measurebowelhealth.com, amazon and in Boots. Bowel Cancer (also called Colorectal cancer) is the third most common cancer worldwide and is the second most common cause of cancer deaths in the United States. It is estimated that there will be 146,970 new cases diagnosed in the United States in 2009.
Screening campaigns have demonstrated the power of early detection in reducing mortality rates. As a result, all Western and many Asian healthcare authorities are now slowly introducing population based screening. The market implications are significant; already forty million tests ($700M) are performed worldwide annually with potential to grow to 250 million.
MODE has assembled a strong management and advisory team with extensive experience in developing and commercialising pioneering diagnostic products. MODE’s rapid commercialisation approach engages both technology and sales & marketing partners to maximise market impact and reach.